Nevertheless, this is the first study showcasing a single therapeutic dose of NV118 in LS patient cells harboring pathogenic mtDNA mutations in the MTATP6, MTND3, and MTND5 genes affecting complexes I and V of the electron transport chain. The gene discussed is MT-ND5; the disease is Leigh syndrome.